接种后、感染后及混合免疫对SARS-CoV-2奥密克戎亚变异感染所致重症COVID-19和长COVID的保护效果,捷克,2021年12月至2023年8月
该研究利用捷克2021年12月至2023年8月的国家层面数据,采用含时变协变量的Cox回归和logistic回归,评估接种后、感染后及混合免疫对需氧支持的SARS-CoV-2 BA1/2和BA4/5+变异感染所致重症及长COVID的保护效果。近期加强接种、感染后和混合免疫对重症COVID-19提供显著保护,而超过10个月未加强接种的疫苗保护效果可忽略;感染后既往免疫对长COVID仅起较小保护作用。
要点
- 近期加强接种、感染后及混合免疫对需氧支持的COVID-19重症提供显著保护。
- 超过10个月未加强接种的疫苗对重症保护效果可忽略。
- 感染后既往免疫对长COVID仅起较小保护作用。
核心结论
- 接种仍是预防COVID-19重症的有效措施,但效果随时间减弱,凸显加强针的重要性。
- 一旦感染,疫苗对长COVID的发生可能具有较小保护作用。
研究设计与样本
- 研究使用捷克2021年12月至2023年8月的国家层面数据。
- 采用含时变协变量和日历时间的Cox回归分析及logistic回归。
主要发现
- 近期加强接种、感染后和混合免疫对COVID-19重症提供显著保护。
- 超过10个月未加强接种的疫苗保护效果可忽略。
- 针对BA1/2或BA4/5+变异的接种后免疫,尤其是基于原始疫苗类型者,与感染后和混合免疫相比似乎迅速减弱。
- 一旦感染,既往免疫对长COVID仅起较小保护作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundCOVID-19 remains a major infectious disease with substantial implications for individual and public health including the risk of a post-infection syndrome, long COVID. The continuous changes in dominant variants of SARS-CoV-2 necessitate a careful study of the effect of preventative strategies.AimWe aimed to estimate the effectiveness of post-vaccination, post-infection and hybrid immunity against severe cases requiring oxygen support caused by infections with SARS-CoV-2 variants BA1/2 and BA4/5+, and against long COVID in the infected population and their changes over time.MethodsWe used a Cox regression analysis with time-varying covariates and calendar time and logistic regression applied to national-level data from Czechia from December 2021 until August 2023.ResultsRecently boosted vaccination, post-infection and hybrid immunity provide significant protection against a severe course of COVID-19, while unboosted vaccination more than 10 months ago has a negligible protective effect. The post-vaccination immunity against the BA1/2 or BA4/5+ variants, especially based on the original vaccine types, appears to wane rapidly compared with post-infection and hybrid immunity. Once infected, however, previous immunity plays only a small protective role against long COVID.ConclusionVaccination remains an effective preventative measure against a severe course of COVID-19 but its effectiveness wanes over time thus highlighting the importance of booster doses. Once infected, vaccines may have a small protective effect against the development of long COVID.
引用
- Šmíd M, Barusová T, Jarkovský J, et al. Post-vaccination, post-infection and hybrid immunity against severe cases of COVID-19 and long COVID after infection with SARS-CoV-2 Omicron subvariants, Czechia, December 2021 to August 2023. Euro Surveill. 2024. PMID: 39212062. doi:10.2807/1560-7917.ES.2024.29.35.2300690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。